With regard to the predictive value for treatment in lung cancer, it also found that patients with FGFR1 amplification could benefit from adjuvant chemotherapy [25], but it cannot be validated in our analysis for lacking of more studies in lung cancer. Here, FGFR1 is linked to lung carcinoma.